This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT A. UTTERBACK, MD; PHILLIP H. TENNEY, MD

Arch Neurol. 1963;9(5):555-560.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Tetanus is one of the most dreaded complications of wounds¹ and continues to be a serious clinical problem in some areas of the world. In areas where some form of preventive medicine is practiced for even the poorest members of the community, tetanus toxoid has made the disease a rarity, a clinical curiosity. It should be noted, though, where tetanus does occur the mortality rate remains high. Neither tetanus antitoxin nor antibiotics have improved mortality greatly in those who developed the typical symptoms.⁶ For example, though the US Army experienced in World War II only 12 cases of tetanus, five of these 12 resulted in death from tetanus.⁹

It seems clearly established that there is a correlation between the length of time elapsing from the date of exposure until the first clinical sign and the prognosis for the case.^4,5,8 The shorter the length of time . . . [Full Text PDF of this Article]

Author Affiliations
MEMPHIS

Footnotes
Submitted for publication June 18, 1963; accepted Aug 15.

Chairman, Division of Neurology, University of Tennessee, College of Medicine (Dr. Utterback); Resident in Neurology, City of Memphis Hospitals and University of Tennessee, College of Medicine (Dr. Tenney).

Now resident in Neurology, Charity Hospital and Louisiana State University, School of Medicine, New Orleans (Dr. Tenney).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?